Role of cancer stem cells in racial disparity in colorectal cancer

Cancer Medicine

Volumn 5, Issue 6, 2016, Pages 1268-1278

  Farhana, Lulu ^a,c   Antaki, Fadi ^a   Anees, Mohammad R ^a   Nangia Makker, Pratima ^a,b,c   Judd, Stephanie ^a   Hadden, Timothy ^a,c   Levi, Edi ^a,c   Murshed, Farhan ^a   Yu, Yingjie ^a,c   Van Buren, Eric ^b,c   Ahmed, Kulsoom ^a   Dyson, Gregory ^b   Majumdar, Adhip P N ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenoma; African Americans; cancer stem cells; colorectal cancer; lncRNA; microRNA; miR 1207 5p; White Americans

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CD133 ANTIGEN; GELATINASE A; HERMES ANTIGEN; LONG UNTRANSLATED RNA; MICRORNA; MIR 1207 5P; NERVE CELL ADHESION MOLECULE; PLASMACYTOMA VARIANT TRANSLOCATION 1; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; AFRICAN AMERICAN; ARTICLE; CANCER RISK; CANCER STEM CELL; CAUCASIAN; COLORECTAL ADENOMA; COLORECTAL CANCER; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT;

EID: 85006224611     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.690     Document Type: Article

References (52)

1. Jemal, A., F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman. 2011. Global cancer statistics. CA Cancer J. Clin. 61:69–90.
2. Dimou, A., K. N. Syrigos, and M. W. Saif. 2009. Disparities in colorectal cancer in African-Americans vs Whites: before and after diagnosis. World J. Gastroenterol. 15:3734–3743.
3. Siegel, R., D. Naishadham, and A. Jemal. 2012. Cancer statistics, 2012. CA Cancer J. Clin. 62:10–29.
4. Lieberman, D. A., J. L. Holub, M. D. Moravec, G. M. Eisen, D. Peters, and C. D. Morris. 2008. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA 300:1417–1422.
5. Wallace, K., E. G. Hill, D. N. Lewin, G. Williamson, S. Oppenheimer, M. E. Ford, et al. 2013. Racial disparities in advanced-stage colorectal cancer survival. Cancer Causes Control 24:463–471.
6. Ries, L. A., P. A. Wingo, D. S. Miller, H. L. Howe, H. K. Weir, H. M. Rosenberg, et al. 2000. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 88:2398–2424.
7. Alexander, D., N. Jhala, C. Chatla, J. Steinhauer, E. Funkhouser, C. S. Coffey, et al. 2005. High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas. Cancer 103:2163–2170.
8. Weber, T. K., H. M. Chin, M. Rodriguez-Bigas, B. Keitz, R. Gilligan, L. O'Malley, et al. 1999. Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer. JAMA 281:2316–2320.
9. Balbinotti, R. A., U. Jr Ribeiro, P. Sakai, A. V. Safatle-Ribeiro, S. S. Balbinotti, C. Scapulatempo, et al. 2007. hMLH1, hMSH2 and cyclooxygenase-2 (cox-2) in sporadic colorectal polyps. Anticancer Res. 27:4465–4471.
10. Birgander, R., A. Sjalander, A. Rannug, A. K. Alexandrie, M. I. Sundberg, J. Seidegard, et al. 1995. P53 polymorphisms and haplotypes in lung cancer. Carcinogenesis 16:2233–2236.
11. Carey, L. A., C. M. Perou, C. A. Livasy, L. G. Dressler, D. Cowan, K. Conway, et al. 2006. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502.
12. Jones, B. A., S. V. Kasl, C. L. Howe, M. Lachman, R. Dubrow, M. M. Curnen, et al. 2004. African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics. Cancer 101:1293–1301.
13. Sieber, O. M., L. Lipton, M. Crabtree, K. Heinimann, P. Fidalgo, R. K. Phillips, et al. 2003. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N. Engl. J. Med. 348:791–799.
14. Plaschke, J., C. Kruppa, R. Tischler, T. Bocker, S. Pistorius, H. Dralle, et al. 2000. Sequence analysis of the mismatch repair gene hMSH6 in the germline of patients with familial and sporadic colorectal cancer. Int. J. Cancer 85:606–613.
15. Kang, M., X. J. Shen, S. Kim, F. Araujo-Perez, J. A. Galanko, C. F. Martin, et al. 2013. Somatic gene mutations in African Americans may predict worse outcomes in colorectal cancer. Cancer Biomark. 13:359–366.
16. Heppner, G. H. 1984. Tumor heterogeneity. Cancer Res. 44:2259–2265.
17. Ricci-Vitiani, L., E. Fabrizi, E. Palio, and R. De Maria. 2009. Colon cancer stem cells. J. Mol. Med. (Berl) 87:1097–1104.
18. Visvader, J. E., and G. J. Lindeman. 2008. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8:755–768.
19. Leavell, B. J., E. Van Buren, F. Antaki, B. N. Axelrod, M. A. Rambus, and A. P. Majumdar. 2012. Associations between markers of colorectal cancer stem cells and adenomas among ethnic groups. Dig. Dis. Sci. 57:2334–2339.
20. Stallmach, A., B. von Lampe, H. Matthes, G. Bornhoft, and E. O. Riecken. 1992. Diminished expression of integrin adhesion molecules on human colonic epithelial cells during the benign to malign tumour transformation. Gut 33:342–346.
21. Farhana, L., M. I. Dawson, F. Murshed, J. K. Das, A. K. Rishi, and J. A. Fontana. 2013. Upregulation of miR-150* and miR-630 induces apoptosis in pancreatic cancer cells by targeting IGF-1R. PLoS ONE 8:e61015.
22. Yu, Y., S. S. Kanwar, B. B. Patel, J. Nautiyal, F. H. Sarkar, and A. P. Majumdar. 2009. Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX. Transl Oncol. 2:321–328.
23. Kong, D., A. Ahmad, B. Bao, Y. Li, S. Banerjee, and F. H. Sarkar. 2012. Histone deacetylase inhibitors induce epithelial-to-mesenchymal transition in prostate cancer cells. PLoS ONE 7:e45045.
24. Yu, Y., P. Nangia-Makker, and A. P. N. Majumdar. 2014. Overcoming drug resistance in colorectal cancer by MicroRNAs. Pp. 139–156 in F. H. Sarkar, ed. McroRNA Targeted Cancer Therapy. Springer, New York.
25. Engels, B. M., and G. Hutvagner. 2006. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene 25:6163–6169.
26. Lee, R. C., R. L. Feinbaum, and V. Ambros. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843–854.
27. Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297.
28. Lewis, B. P., C. B. Burge, and D. P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20.
29. Yu, Y., P. Nangia-Makker, L. Farhana, S.G. Rajendra, E. Levi, andA.P. Majumdar. 2015. miR-21 and miR-145 cooperation in regulation of colon cancer stem cells. Mol. Cancer. 14:98.
30. Zhu, J., L. Chen, L. Zou, P. Yang, R. Wu, Y. Mao, et al. 2014. MiR-20b, -21, and -130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer. Hum. Immunol. 75:348–353.
31. Watabe, T., and K. Miyazono. 2009. Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Res. 19:103–115.
32. Schulenburg, A., P. Cech, I. Herbacek, B. Marian, F. Wrba, P. Valent, et al. 2007. CD44-positive colorectal adenoma cells express the potential stem cell markers musashi antigen (msi1) and ephrin B2 receptor (EphB2). J Pathol. 213:152–160.
33. Kessenbrock, K.C.Y. Wang, and Z. Werb. 2015. Matrix metalloproteinases in stem cell regulation and cancer.Matrix Biol. 44-46C:184–190.
34. Horwich, M. D., and P. D. Zamore. 2008. Design and delivery of antisense oligonucleotides to block microRNA function in cultured Drosophila and human cells. Nat. Protoc. 3:1537–1549.
35. Jordan, C. T., M. L. Guzman, and M. Noble. 2006. Cancer stem cells. N. Engl. J. Med. 355:1253–1261.
36. Todaro, M., M. D'Asaro, N. Caccamo, F. Iovino, M. G. Francipane, S. Meraviglia, et al. 2009. Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes. J Immunol. 182:7287–7296.
37. Clevers, H. 2011. The cancer stem cell: premises, promises and challenges. Nat. Med. 17:313–319.
38. Dalerba, P., S. J. Dylla, I. K. Park, R. Liu, X. Wang, R. W. Cho, et al. 2007. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A. 104:10158–10163.
39. Patel, B. B., Y. Yu, J. Du, E. Levi, P. A. Phillip, and A. P. Majumdar. 2009. Age-related increase in colorectal cancer stem cells in macroscopically normal mucosa of patients with adenomas: a risk factor for colon cancer. Biochem. Biophys. Res. Commun. 378:344–347.
40. Levi, E., S. Misra, J. Du, B. B. Patel, and A. P. Majumdar. 2009. Combination of aging and dimethylhydrazine treatment causes an increase in cancer-stem cell population of rat colonic crypts. Biochem. Biophys. Res. Commun. 385:430–433.
41. Rossi, D. J., C. H. Jamieson, and I. L. Weissman. 2008. Stems cells and the pathways to aging and cancer. Cell 132:681–696.
42. Levi, E., P. Sochacki, N. Khoury, B. B. Patel, and A. P. Majumdar. 2014. Cancer stem cells in Helicobacter pylori infection and aging: implications for gastric carcinogenesis. World J Gastrointest Pathophysiol. 5:366–372.
43. Bessede, E., C. Staedel, L. A. Acuna Amador, P. H. Nguyen, L. Chambonnier, M. Hatakeyama, et al. 2014. Helicobacter pylori generates cells with cancer stem cell properties via epithelial-mesenchymal transition-like changes. Oncogene 33:4123–4131.
44. Yu, Y., S. S. Kanwar, B. B. Patel, P. S. Oh, J. Nautiyal, F. H. Sarkar, et al. 2012. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFbetaR2) in colon cancer cells. Carcinogenesis 33:68–76.
45. Colombo, T., L. Farina, G. Macino, and P. Paci. 2015. PVT1: a Rising Star among Oncogenic Long Noncoding RNAs. Biomed Res Int. 2015:304208.
46. Pena-Chilet, M., M. T. Martinez, J. A. Perez-Fidalgo, L. Peiro-Chova, S. S. Oltra, E. Tormo, et al. 2014. MicroRNA profile in very young women with breast cancer. BMC Cancer 14:529.
47. Tran, D. D., C. A. Corsa, H. Biswas, R. L. Aft, and G. D. Longmore. 2011. Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence. Mol. Cancer Res. 9:1644–1657.
48. Shtivelman, E., and J. M. Bishop. 1989. The PVT gene frequently amplifies with MYC in tumor cells. Mol. Cell. Biol. 9:1148–1154.
49. Shtivelman, E., and J. M. Bishop. 1990. Effects of translocations on transcription from PVT. Mol. Cell. Biol. 10:1835–1839.
50. Barsotti, A. M., R. Beckerman, O. Laptenko, K. Huppi, N. J. Caplen, and C. Prives. 2012. p53-Dependent induction of PVT1 and miR-1204. J. Biol. Chem. 287:2509–2519.
51. Beck-Engeser, G. B., A. M. Lum, K. Huppi, N. J. Caplen, B. B. Wang, and M. Wabl. 2008. Pvt1-encoded microRNAs in oncogenesis. Retrovirology. 5:4.
52. Tseng, Y. Y., B. S. Moriarity, W. Gong, R. Akiyama, A. Tiwari, H. Kawakami, et al. 2014. PVT1 dependence in cancer with MYC copy-number increase. Nature 512:82–86.